Company Profiles

driven by the PitchBook Platform

Xagenic

Xagenic
2010 FOUNDED
PRIVATE STATUS
41-50 EMPLOYEES
Series B LATEST DEAL TYPE
$11.7M LATEST DEAL AMOUNT
12 INVESTORS
Description

Developer of molecular diagnostics technology. The company provides a fully automated technology platform that enables widespread decentralized diagnostic testing to be performed outside of clinical laboratories.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Clinics/Outpatient Services
Primary Office
55 York Street
Suite 1000
Toronto, Ontario M5J 1R7
Canada

+1 (416) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Xagenic’s full profile, request a free trial.

Xagenic Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 09-Jul-2015 $11.7M 000.00 Completed Generating Revenue
5. Grant 15-Oct-2014 000 000.00 Completed Startup
4. Early Stage VC (Series B) 14-Jul-2014 000.00 000.00 Completed Startup
3. Grant 19-Feb-2013 00000 0000 Completed Startup
2. Early Stage VC (Series A) 30-Jan-2012 $9.8M $12M Completed Startup
1. Seed Round 01-Jan-2010 $2.11M $2.11M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Xagenic Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
MaRS Innovation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Ontario Ministry of Research and Innovation Government 000 0000 000000 0
BDC Healthcare Venture Fund Venture Capital Minority 000 0000 000000 0
Domain Associates Venture Capital Minority 000 0000 000000 0
Ontario Emerging Technologies Fund Government Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Xagenic Executive Team (13)

Name Title Board
Seat
Contact
Info
Mike Wood Director, Product Development
Ihor Boszko Vice President, Business Development
Graham Jack Ph.D Vice President, Research
Shana Kelley Ph.D Co-Founder, Chief Executive Officer, Chief Technology Officer & Board Member
Edward Jonasson Chief Financial Officer

7 Former Executives

You’re viewing 5 of 13 executives. Get the full list »

Xagenic Board Members (8)

Name Representing Role Since Contact
Info
Dion Madsen BDC Healthcare Venture Fund Board Member 000 0000
Erik Holmlin Ph.D Self Board Member 000 0000
Jesse Treu Ph.D Domain Associates Board Member 000 0000
Michelle McBane MaRS Investment Accelerator Fund Board Observer 000 0000
Shana Kelley Ph.D Xagenic Co-Founder, Chief Executive Officer, Chief Technology Officer & Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 8 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com